Fund HoldingsPivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value
$168.47M
Total Bought
$22.72M
Total Sold
$13.46M
Net Transaction
+$9.27M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
VAXCYTE INC(PCVX)793,036639,539-153,49759,88273,08043.38%+13,198
ZENAS BIOPHARMA INC(ZBIO)0650,695+650,695011,0106.54%+11,010
BIOAGE LABS INC(BIOA)0527,647+527,647010,9756.51%+10,975
INOZYME PHARMA INC4,494,8514,494,851020,04723,50813.95%+3,461
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,041,1082,120,508+79,40018,98219,72111.71%+738
OCULIS HOLDING AG1,595,9181,595,918019,07119,56611.61%+495
IO BIOTECH INC864,197864,19701,0119070.54%-104
EXSCIENTIA PLC770,500770,50003,9303,7602.23%-170
BOLT BIOTHERAPEUTICS INC1,891,4671,891,46701,4191,2260.73%-193
ALIGOS THERAPEUTICS INC743,2150-743,2152600-260
VIGIL NEUROSCIENCE INC560,595560,59502,2421,9061.13%-336
RALLYBIO CORP2,404,6442,404,64403,2222,8131.67%-409
Page 1 of 1